As of 2025-11-08, the Relative Valuation of Creo Medical Group PLC (CREO.L) is 84.85 GBP. This relative valuation is based on P/E multiples. With the latest stock price at 11.13 GBP, the upside of Creo Medical Group PLC based on Relative Valuation is 662.7%.
The range of the Relative Valuation is 70.73 - 134.17 GBP.
| Range | Selected | |
| Trailing P/E multiples | 19.6x - 32.0x | 20.1x |
| Forward P/E multiples | 16.9x - 23.4x | 20.4x |
| Fair Price | 70.73 - 134.17 | 84.85 |
| Upside | 535.8% - 1106.1% | 662.7% |
| Date | P/E |
| 2025-11-06 | 2.66 |
| 2025-11-05 | 2.57 |
| 2025-11-04 | 2.70 |
| 2025-11-03 | 2.70 |
| 2025-10-31 | 2.70 |
| 2025-10-30 | 2.69 |
| 2025-10-29 | 2.69 |
| 2025-10-28 | 2.70 |
| 2025-10-27 | 2.67 |
| 2025-10-24 | 2.64 |
| 2025-10-23 | 2.63 |
| 2025-10-22 | 2.63 |
| 2025-10-21 | 2.58 |
| 2025-10-20 | 2.57 |
| 2025-10-17 | 2.70 |
| 2025-10-16 | 2.69 |
| 2025-10-15 | 2.66 |
| 2025-10-14 | 2.67 |
| 2025-10-13 | 2.67 |
| 2025-10-10 | 2.70 |
| 2025-10-09 | 2.69 |
| 2025-10-08 | 2.72 |
| 2025-10-07 | 2.81 |
| 2025-10-06 | 2.82 |
| 2025-10-03 | 2.82 |
| 2025-10-02 | 2.78 |
| 2025-10-01 | 2.84 |
| 2025-09-30 | 2.84 |
| 2025-09-29 | 2.94 |
| 2025-09-26 | 2.91 |
| 2025-09-25 | 2.87 |
| 2025-09-24 | 2.93 |
| 2025-09-23 | 2.87 |
| 2025-09-22 | 2.84 |
| 2025-09-19 | 2.91 |
| 2025-09-18 | 2.90 |
| 2025-09-17 | 2.90 |
| 2025-09-16 | 2.90 |
| 2025-09-15 | 2.94 |
| 2025-09-12 | 2.88 |
| 2025-09-11 | 2.99 |
| 2025-09-10 | 3.02 |
| 2025-09-09 | 3.02 |
| 2025-09-08 | 3.09 |
| 2025-09-05 | 3.12 |
| 2025-09-04 | 3.11 |
| 2025-09-03 | 3.14 |
| 2025-09-02 | 3.14 |
| 2025-09-01 | 3.23 |
| 2025-08-29 | 3.18 |